A combined risk score enhances prediction of type 1 diabetes among susceptible children
- 7 August 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Nature Medicine
- Vol. 26 (8), 1247-1255
- https://doi.org/10.1038/s41591-020-0930-4
Abstract
Type 1 diabetes (T1D)—an autoimmune disease that destroys the pancreatic islets, resulting in insulin deficiency—often begins early in life when islet autoantibody appearance signals high risk1. However, clinical diabetes can follow in weeks or only after decades, and is very difficult to predict. Ketoacidosis at onset remains common2,3 and is most severe in the very young4,5, in whom it can be life threatening and difficult to treat6,7,8,9. Autoantibody surveillance programs effectively prevent most ketoacidosis10,11,12 but require frequent evaluations whose expense limits public health adoption13. Prevention therapies applied before onset, when greater islet mass remains, have rarely been feasible14 because individuals at greatest risk of impending T1D are difficult to identify. To remedy this, we sought accurate, cost-effective estimation of future T1D risk by developing a combined risk score incorporating both fixed and variable factors (genetic, clinical and immunological) in 7,798 high-risk children followed closely from birth for 9.3 years. Compared with autoantibodies alone, the combined model dramatically improves T1D prediction at ≥2 years of age over horizons up to 8 years of age (area under the receiver operating characteristic curve ≥ 0.9), doubles the estimated efficiency of population-based newborn screening to prevent ketoacidosis, and enables individualized risk estimates for better prevention trial selection.Funding Information
- JDRF (3-SRA-2019-827-S-B, 3-SRA-2019-827-S-B)
- U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (DK063829, HHSN267200700014C, HHSN267200700014C, HHSN267200700014C, HHSN267200700014C, HHSN267200700014C)
- please see corresponding author list of funders
- U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases
- Diabetes UK (17/0005757, 16/0005529)
- U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases
- U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases
- U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases
- U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases
This publication has 51 references indexed in Scilit:
- Children followed in the TEDDY study are diagnosed with type 1 diabetes at an early stage of diseasePediatric Diabetes, 2013
- Genetics of the HLA Region in the Prediction of Type 1 DiabetesCurrent Diabetes Reports, 2011
- The Environmental Determinants of Diabetes in the Young (TEDDY): genetic criteria and international diabetes risk screening of 421 000 infantsPediatric Diabetes, 2011
- Landmark Analysis at the 25-Year Landmark PointCirculation: Cardiovascular Quality and Outcomes, 2011
- Harmonization of Glutamic Acid Decarboxylase and Islet Antigen-2 Autoantibody Assays for National Institute of Diabetes and Digestive and Kidney Diseases ConsortiaJournal of Clinical Endocrinology & Metabolism, 2010
- Promise and pitfalls of the ImmunochipArthritis Research & Therapy, 2010
- The Environmental Determinants of Diabetes in the Young (TEDDY) StudyAnnals of the New York Academy of Sciences, 2008
- Glucose and C-Peptide Changes in the Perionset Period of Type 1 Diabetes in the Diabetes Prevention Trial–Type 1Diabetes Care, 2008
- Assessment and monitoring of glycemic control in children and adolescents with diabetesPediatric Diabetes, 2007
- Causes of death in children with insulin dependent diabetes 1990-96Archives of Disease in Childhood, 1999